202 related articles for article (PubMed ID: 30763392)
21. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy.
Haka AS; Shafer-Peltier KE; Fitzmaurice M; Crowe J; Dasari RR; Feld MS
Cancer Res; 2002 Sep; 62(18):5375-80. PubMed ID: 12235010
[TBL] [Abstract][Full Text] [Related]
22. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
Looi LM; Cheah PL
Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples.
Kinsella MD; Birdsong GG; Siddiqui MT; Cohen C; Hanley KZ
Diagn Cytopathol; 2013 Mar; 41(3):192-8. PubMed ID: 22611048
[TBL] [Abstract][Full Text] [Related]
24. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of phosphorylated Girdin in breast cancer].
Xu Y; Fu L; Gu F; Ma YJ
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):205-9. PubMed ID: 22780975
[TBL] [Abstract][Full Text] [Related]
26. Distribution of phthalocyanines and Raman reporters in human cancerous and noncancerous breast tissue as studied by Raman imaging.
Brozek-Pluska B; Jarota A; Jablonska-Gajewicz J; Kordek R; Czajkowski W; Abramczyk H
Technol Cancer Res Treat; 2012 Aug; 11(4):317-31. PubMed ID: 22712604
[TBL] [Abstract][Full Text] [Related]
27. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
28. [Study the Raman spectroscopy of breast tumor limbic tissue].
Zhao YL; Lü J; Ge XH; Yao SX; Liang EJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jul; 26(7):1267-71. PubMed ID: 17020037
[TBL] [Abstract][Full Text] [Related]
29. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.
Pegolo E; Machin P; Riosa F; Bassini A; Deroma L; Di Loreto C
Cancer Cytopathol; 2012 Jun; 120(3):196-205. PubMed ID: 22298467
[TBL] [Abstract][Full Text] [Related]
30. A non-invasive modality: the US virtual touch tissue quantification (VTTQ) for evaluation of breast cancer.
Tamaki K; Tamaki N; Kamada Y; Uehara K; Miyashita M; Ishida T; Sasano H
Jpn J Clin Oncol; 2013 Sep; 43(9):889-95. PubMed ID: 23911773
[TBL] [Abstract][Full Text] [Related]
31. Raman spectroscopy for screening and diagnosis of cervical cancer.
Lyng FM; Traynor D; Ramos IR; Bonnier F; Byrne HJ
Anal Bioanal Chem; 2015 Nov; 407(27):8279-89. PubMed ID: 26277185
[TBL] [Abstract][Full Text] [Related]
32. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
33. Resonance Raman and Raman spectroscopy for breast cancer detection.
Liu CH; Zhou Y; Sun Y; Li JY; Zhou LX; Boydston-White S; Masilamani V; Zhu K; Pu Y; Alfano RR
Technol Cancer Res Treat; 2013 Aug; 12(4):371-82. PubMed ID: 23448574
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan.
Sughayer MA; Al-Khawaja MM; Massarweh S; Al-Masri M
Pathol Oncol Res; 2006; 12(2):83-6. PubMed ID: 16799708
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
Bhargava R; Beriwal S; McManus K; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
[TBL] [Abstract][Full Text] [Related]
36. Application of Raman Spectroscopy and Infrared Spectroscopy in the Identification of Breast Cancer.
Depciuch J; Kaznowska E; Zawlik I; Wojnarowska R; Cholewa M; Heraud P; Cebulski J
Appl Spectrosc; 2016 Feb; 70(2):251-63. PubMed ID: 26903561
[TBL] [Abstract][Full Text] [Related]
37. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
38. New aspects in the histological diagnosis of breast carcinoma.
Shousha S
Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
[TBL] [Abstract][Full Text] [Related]
39. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
40. The management of lobular neoplasia identified on percutaneous core breast biopsy.
Bauer VP; Ditkoff BA; Schnabel F; Brenin D; El-Tamer M; Smith S
Breast J; 2003; 9(1):4-9. PubMed ID: 12558663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
